50 Followers on Owler
OverviewCompetitorsFundingNews & Insights

Renova Therapeutics Competitors or Alternatives

Renova Therapeutics's top competitors include uniQure, bluebird bio and Lysogene.

Unlock 8 more competitors →

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

  • FUNDING

    REVENUE

  • EMPLOYEES

    FUNDING

  • REVENUE

  • CEO RATING

  • EMPLOYEES

  • FUNDING

  • REVENUE

Renova Therapeutics's company profile

Vijay Mahant

CEO

82/100
25 - 100
$7.5M
$100K - 5M
  • $7.5M
    $100K - 5M
  • 25 - 100
    $7.5M
  • $100K - 5M
  • 82/100
  • 25 - 100
  • $7.5M
  • $100K - 5M
View ProfileView
1
Renova Therapeutics's Competitor - uniQure logo

Matthew Kapusta

CEO

83/100
209
$163.1M
$27.1M
  • $163.1M
    $27.1M
  • 209
    $163.1M
  • $27.1M
  • 83/100
  • 209
  • $163.1M
  • $27.1M
View ProfileView
2
Renova Therapeutics's Competitor - bluebird bio logo

Andrew Obenshain

CEO

73/100
520
$821.4M
$83.8M
  • $821.4M
    $83.8M
  • 520
    $821.4M
  • $83.8M
  • 73/100
  • 520
  • $821.4M
  • $83.8M
View ProfileView
3
Renova Therapeutics's Competitor - Lysogene logo

Karen Pignet-Aiach

Chairman & CEO

90/100
22
$82.9M
$16.4M
  • $82.9M
    $16.4M
  • 22
    $82.9M
  • $16.4M
  • 90/100
  • 22
  • $82.9M
  • $16.4M
View ProfileView
4
Renova Therapeutics's Competitor - Dimension Therapeutics logo

Annalisa Jenkins

CEO

79/100
100 - 250
$191M
$5M - 25M
  • $191M
    $5M - 25M
  • 100 - 250
    $191M
  • $5M - 25M
  • 79/100
  • 100 - 250
  • $191M
  • $5M - 25M
View ProfileView
5
Renova Therapeutics's Competitor - Sangamo logo

Sandy Macrae

President & CEO

68/100
480
$71.5M
$57.8M
  • $71.5M
    $57.8M
  • 480
    $71.5M
  • $57.8M
  • 68/100
  • 480
  • $71.5M
  • $57.8M
View ProfileView
Renova Therapeutics' top 11 competitors are uniQure, bluebird bio, Lysogene, Prevail Therapeutics, Dimension Therapeutics, Sangamo, Corvidia, Dyno Therapeutics, Kriya, Ring Therapeutics and Nectero Medical. Together they have raised over 3.1B between their estimated 2.1K employees. Renova Therapeutics's revenue is the ranked 9th among it's top 10 competitors. The top 10 competitors average 27.1M. Renova Therapeutics has 35 employees and is ranked 9th among it's top 10 competitors. The top 10 competitors average 176.

Renova Therapeutics VS uniQure

uniQure is Renova Therapeutics's top competitor. uniQure is headquartered in Amsterdam, Noord-Holland, and was founded in 1998. Like Renova Therapeutics, uniQure also operates in the Biotechnology field. uniQure generates 564% the revenue of Renova Therapeutics.

Renova Therapeutics VS bluebird bio

bluebird bio is seen as one of Renova Therapeutics's top competitors. bluebird bio's headquarters is in Somerville, Massachusetts, and was founded in 1992. Like Renova Therapeutics, bluebird bio also works within the Biotechnology industry. bluebird bio generates 1,745% of Renova Therapeutics's revenue.

Renova Therapeutics VS Lysogene

Lysogene has been one of Renova Therapeutics's top competitors. Lysogene was founded in 2009, and its headquarters is in Neuilly-sur-Seine, Île-de-France. Like Renova Therapeutics, Lysogene also works within the Biotechnology field. Lysogene has 13 fewer employees than Renova Therapeutics.

Looking for similar companies to Renova Therapeutics?

Similar Companies

Biotechnology companies in San Diego

See 553 companies 
Pharmaceuticals & Biotechnology companies in San Diego

See 720 companies 
Biotechnology companies in San Diego County

See 687 companies 
Pharmaceuticals & Biotechnology companies in San Diego County

See 904 companies 
Biotechnology companies in California

See 3,097 companies 
Pharmaceuticals & Biotechnology companies in California

See 4,181 companies 
Biotechnology companies with revenue in $100K-5.0M range

See 4,537 companies 
Biotechnology companies with employees in 25-100 range

See 5,165 companies 
Pharmaceuticals & Biotechnology companies with revenue in $100K-5.0M range

See 6,045 companies 

Advanced Search

PRO

Discover new companies using five search parameters, including sector, location, public/private company status, employee count, and annual revenue.

Discover new companies using five search parameters.

Trending News for Renova Therapeutics and Renova Therapeutics's Competitors

April 1, 2025Medthority
Bluebird Bio receives an acquisition offer from Ayrmid Ltd, signaling potential changes in the company's future....
April 3, 2025centralcharts
ZUG, Switzerland and BOSTON, April 03, 2025 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating...
April 1, 2025Benzinga
NEW YORK, April 01, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Intellia Therapeutics, Inc. ("Intellia" or the "Company") NTLA...
April 2, 2025PR-Inside
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / April 2, 2025 /WHY: New York, N.Y., April 2, 2025. Rosen Law Firm, a global investor rights law f...
April 3, 2025centralcharts
Intellia Therapeutics, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before April 14, 2025 to Discuss Your Rights - NT...
April 3, 2025centralcharts
CAMBRIDGE, Mass., April 03, 2025 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused o...
April 3, 2025PR-Inside
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / April 3, 2025 /WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of secu...
April 1, 2025PR Newswire
/PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Intellia Therapeutics, Inc. ("Intellia" or the "Company") (NASDAQ: NTLA) of a class action....

Frequently Asked Questions about Renova Therapeutics

  1. Who are Renova Therapeutics's top competitors?

    Renova Therapeutics's top 3 competitors are uniQure, bluebird bio, Lysogene.

  2. Who is similar to Renova Therapeutics?

    uniQure is the most similar to Renova Therapeutics. bluebird bio and Lysogene are also similar to Renova Therapeutics.

  1. Are Renova Therapeutics and uniQure competitors?

    Yes, uniQure is one of Renova Therapeutics’s top competitors.